Labour market · 17/11/20261 min read
Laboratoires Pierre Fabre: FDA Fast Track designation for elticertinib in NSCLC
Summary
CASTRES, France, Nov. 17, 2026 — Laboratoires Pierre Fabre announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to elticertinibi (also known as PFL-721 previously STX-721), for the treatment of adult patients with locally advanced or...